|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Witzens-Harig, Mathias; Viardot, Andreas; Keller, Ulrich; Wosniok, Julia; Deuster, Oliver; Klemmer, Jennifer; Geueke, Anne-Marie; Meissner, Julia; Ho, Anthony D.; Atta, Johannes; Marks, Reinhard; La Rosee, Paul; Buske, Christian; Dreyling, Martin H. und Hess, Georg
(2021):
The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL - Results From the Phase-II STORM Trial.
In: Hemasphere, Bd. 5, Nr. 10, e636
Schwaab, Juliana; Naumann, Nicole; Luebke, Johannes; Jawhar, Mohamad; Somervaille, Tim C. P.; Williams, Mark S.; Frewin, Rebecca; Jost, Philipp J.; Lichtenegger, Felix S.; La Rosee, Paul; Storch, Nicola; Haferlach, Torsten; Horny, Hans-Peter; Fabarius, Alice; Haferlach, Claudia; Burchert, Andreas; Hofmann, Wolf-Karsten; Cross, Nicholas C. P.; Hochhaus, Andreas; Reiter, Andreas und Metzgeroth, Georgia
(2020):
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
In: American Journal of Hematology, Bd. 95, Nr. 7: S. 824-833
Hess, Georg; Wagner, Karola; Keller, Ulrich; La Rosee, Paul; Atta, Johannes; Hübel, Kai; Lerchenmueller, Christian; Schoendube, Daniel; Witzens-Harig, Mathias; Ruckes, Christian; Medler, Christoph; Oordt, Christina van; Klapper, Wolfram; Theobald, Matthias und Dreyling, Martin
(2020):
Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.
In: Hemasphere, Bd. 4, Nr. 3, e398
Saussele, Susanne; Haverkamp, Wilhelm; Lang, Fabian; Koschmieder, Steffen; Kiani, Alexander; Jentsch-Ullrich, Kathleen; Stegelmann, Frank; Pfeifer, Heike; La Rosee, Paul; Goekbuget, Nicola; Rieger, Christina; Waller, Cornelius F.; Franke, Georg-Nikolaus; le Coutre, Philipp; Kirchmair, Rudolf und Junghanss, Christian
(2020):
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
In: Acta Haematologica, Bd. 143, Nr. 3: S. 217-231